ALLR - Allarity Therapeutics Inc

https://www.allarity.com

Momentum: Bearish

Recent News

Are Medical Stocks Lagging Boston Scientific ( BSX ) This Year?

Zacks Commentary • 2 weeks, 3 days ago • score: 0.34

Here is how Boston Scientific (BSX) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.

Bullish

Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday - ATN International ( NASDAQ:ATNI ) , Allarity Therapeutics ( NASDAQ:ALLR )

Benzinga • 4 weeks ago • score: 0.31

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Palo Alto Networks Inc PANW to report quarterly earnings at 89 cents per share on revenue of $2.50 billion after the closing bell, according to ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark.

52W High

$4.47

52W Low

$0.61

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.15

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

0.34

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.08

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

2.37

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

2.71%

Institutions (25–75% balanced)

1.95%

Shares Outstanding

14,619,600

Float

14,619,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

-7,127,000

Gross Profit (TTM)

-36,348,000

EPS (TTM)

5.75

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-1.51%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.2811

0.2840

Trend

Falling

Signal Cross

No cross

As of

Sep. 11, 2025